# Novo Nordisk Pharma

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/novo-nordisk-pharma/

## Facts

| Field | Value |
| --- | --- |
| Country | JP |
| OpenAlex ID | https://openalex.org/F4320333876 |
| Works | 869 |

## Funder papers

- [Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes](https://scholariq.org/papers/semaglutide-and-cardiovascular-outcomes-in-obesity-without-diabetes/)
- [Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial](https://scholariq.org/papers/long-term-kidney-outcomes-of-semaglutide-in-obesity-and-cardiovascular-disease/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.